Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Treasury Shares (2016 - 2025)

Iradimed (IRMD) has disclosed Treasury Shares for 9 consecutive years, with $44251.0 as the latest value for Q4 2024.

  • On a quarterly basis, Treasury Shares fell 68.69% to $44251.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $44251.0, a 68.69% decrease, with the full-year FY2024 number at $44251.0, up 20.27% from a year prior.
  • Treasury Shares was $1.8 million for Q3 2017 at Iradimed, up from $1.6 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $269609.0 in Q1 2020 to a low of $11891.0 in Q4 2020.
  • A 5-year average of $117126.0 and a median of $141585.5 in 2020 define the central range for Treasury Shares.
  • Biggest YoY gain for Treasury Shares was 81.76% in 2017; the steepest drop was 84.42% in 2017.
  • Iradimed's Treasury Shares stood at $10.0 million in 2016, then tumbled by 81.76% to $1.8 million in 2017.
  • Per Business Quant, the three most recent readings for IRMD's Treasury Shares are $44251.0 (Q4 2024), $141327.0 (Q4 2023), and $151337.0 (Q4 2022).